In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Biomarker targeted approach in preventing heart failure among patients with diabetes
Session

Event : Heart Failure 2018

Topic : Chronic Heart Failure – Prevention

  • Session type : Satellite Symposium
  • Date : 27 May 2018
  • Time : 12:45 - 13:45
  • Sponsored by Roche

4 presentations in this session

Heart failure as a serious but preventable complication of T2DM (Type 2 Diabetes Mellitus) – metabolic physician perspective.

Event : Heart Failure 2018

  • Session : Biomarker targeted approach in preventing heart failure among patients with diabetes
  • Speaker : N Sattar (Glasgow,GB)
  • Sponsored by Roche

Heart failure as a serious but preventable complication of T2DM – cardiologist perspective.

Event : Heart Failure 2018

  • Session : Biomarker targeted approach in preventing heart failure among patients with diabetes
  • Speaker : M Pfeffer (Boston,US)
  • Sponsored by Roche

How biomarkers could help in identifying T2DM patients at risk of cardiovascular events?

Event : Heart Failure 2018

  • Session : Biomarker targeted approach in preventing heart failure among patients with diabetes
  • Speaker : M Huelsmann (Vienna,AT)
  • Sponsored by Roche

Role of biomarkers in CVD intensive preventive therapy among T2DM - current guidelines and future perspectives.

Event : Heart Failure 2018

  • Session : Biomarker targeted approach in preventing heart failure among patients with diabetes
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Roche

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are